List of Gene Editing/CRISPR Companies in Wisconsin - 5

L'Alliance Boviteq (LAB) inc. is an embryo transfer centre located in Saint-Hyacinthe, Québec, Canada, about 50 km east of Montréal. It is a very unique enterprise highly specialized in the production of bovine embryos using both in vivo and in vitro technology. LAB is linked to The Semex Alliance and is an important part of its research and development program. Research and development (R & D) LAB has a significant involvement in research and development in order to provide state-of-the-art technologies in reproduction to our customers. This involves the investigation and application of new technologies in bovine reproduction in order to provide the cattle breeding industry with the tools needed to produce superior genetics such as sexing of embryos, freezing sexed embryos and production of embryos from in vitro fertilization of oocytes. Our scientific and professional staff work in close collaboration with government and university researchers in order to bridge the gap between basic and applied research. Besides owning and housing livestock, LAB has well equipped laboratories and competent personnel, thus providing opportunities to undertake research projects with other organizations. Services to breeders LAB offers breeders a wide variety of services such as conventional embryo collection, in vitro fertilization as well as treatment of repeat breeders. LAB is the privileged place for breeders who wish to get specialized services for their donor cows. TYPE OF SERVICES AVAILABLE ·Housing of donor females ·Collection and freezing of embryos ·Embryo sexing ·Oocyte recovery and in vitro fertilization ·Recipients on site to produce guaranteed pregnancies ·Ultrasonography to confirm early pregnancies and foetal sexing ·Treatment of repeat breeders HEALTH STATUS Our installations can provide housing of leucosis positive donors, as well as maintaining the status of leucosis free donors. Our recipient herd is free of leucosis, neospora and BVD. LAB is accredited by Agriculture and Agri-Food Canada for embryo export to the EEC and other markets. Achievements in R & D include: -First heifer born from a split embryo and first identical twin in 1990 -Numerous calves resulting from embryos produced by in vitro fertilization (IVF) -In vitro fertilisation of oocytes collected on farm and transported to LAB -Embryo sexing by molecular probe, including sexing of IVF embryos produced at LAB -Freezing of sexed embryos -Embryo culture -Ultrasound technology, including fetal sexing -Improvement of superovulatory response PRODUCTS AVAILABLE ·Frozen embryos, quality 1 and 2 ·Sexed frozen embryos ·Heifer calves, 3 to 9 months of age Contact us by phone (450-774-7949) or fax (450-774-1740) for a list of embryos or calves for sale.

Cultured Decadence is a Wisconsin-based cellular agriculture company using cell culture and tissue engineeringtechnologies to make lobster meat directly from the animal's cells.

Wholesale Micropropagation, The Product: Isolation into sterile culture, scaleup cloning, and marketing to wholesale growers of unique, high value plant specimens, specializing in contracts as exclusive propagator of patented woody ornamental plants and previously difficulttomultiply specimens. Spinoff Technology: A plant reproduction (cloning) method using sterile testtube culture, called micropropagation. The History: The technology was first perfected at UWMadison in the late 70's in the laboratory of Professor Brent McCown. After successful demonstration projects conducted by UW/industry cooperators, KHN was established to meet the demand for such services.

OUR MISSION: Deliver Innovation. Empower Discovery. Improve Life. For over 25 years, Mirus Bio has pioneered the development of transfection reagents and proprietary technologies for nucleic acid delivery applications. Our work is both technical and cutting-edge, and we promote a culture of creativity, responsibility, and respect. Our team members are engaged and motivated by the desire to support our customers and partners to achieve strong results. Mirus, together with Gamma Biosciences, is establishing the future of science and medicine by developing products that enable product developers within the cell and gene therapy space. As we approach a new era of addressing and conquering life-altering diseases, we will continue to expand our expertise and leadership in transfection to be integral in the future of advanced therapies.